Anemia
Feature
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...
Latest News
Consider mental health and social factors in management of sickle cell disease
Screen sickle cell disease patients for depression and mental health issues, especially those reporting higher levels of pain.
From the Journals
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
From the Journals
SCD meds: Why such ‘slow uptake’?
A nationwide study found that pain medications approved to treat sickle cell disease were prescribed to fewer than one in three patients with SCD...
From the Journals
VEXAS syndrome: More common, variable, and severe than expected
A large U.S. analysis found that this newly discovered genetic disease has a estimated prevalence of 1 in 4,269 in men older than 50.
Conference Coverage
Study: Formula-fed extreme preemies need more iron
It’s time to rethink the guidelines on nutritional supplementation for the most premature babies, researchers said.
Conference Coverage
Alloantibody registry would save lives, money
New research supports establishing a national exchange of alloantibody data, to save lives and cut costs in transfusion medicine.
Conference Coverage
Pricey gene therapy looks cost-effective for SCD
Researchers calculated that a costly new treatment being developed for sickle cell disease (SCD) promises to be worth the price.
Feature
Post Roe, pregnant SCD patients facing “dire” risks
Doctors warn that lost abortion rights put many pregnant patients with sickle cell disease (SCD) in danger.
News from the FDA/CDC
FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic...